Found: 4
Select item for more details and to access through your institution.
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1757, doi. 10.1002/ajh.27413
- By:
- Publication type:
- Article
Pixantrone beyond monotherapy: a review.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 499, doi. 10.1111/ejh.13392
- By:
- Publication type:
- Article
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 381, doi. 10.1007/s12185-022-03367-z
- By:
- Publication type:
- Article